Concepts (120)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Emergency Medical Services | 13 | 2023 | 238 | 3.750 |
Why?
|
| Automobiles | 2 | 2014 | 13 | 0.960 |
Why?
|
| Bicycling | 2 | 2014 | 12 | 0.960 |
Why?
|
| Accidents, Traffic | 2 | 2014 | 98 | 0.880 |
Why?
|
| Out-of-Hospital Cardiac Arrest | 3 | 2022 | 93 | 0.870 |
Why?
|
| Telemedicine | 1 | 2023 | 188 | 0.690 |
Why?
|
| Cardiopulmonary Resuscitation | 3 | 2022 | 223 | 0.670 |
Why?
|
| Emergency Responders | 1 | 2017 | 7 | 0.580 |
Why?
|
| Withholding Treatment | 1 | 2017 | 117 | 0.540 |
Why?
|
| Naloxone | 2 | 2013 | 67 | 0.520 |
Why?
|
| Disaster Medicine | 1 | 2014 | 1 | 0.490 |
Why?
|
| Delivery of Health Care | 2 | 2021 | 435 | 0.490 |
Why?
|
| Acute Coronary Syndrome | 1 | 2015 | 30 | 0.480 |
Why?
|
| Narcotic Antagonists | 2 | 2013 | 160 | 0.470 |
Why?
|
| Patient Admission | 1 | 2014 | 114 | 0.470 |
Why?
|
| Aspirin | 1 | 2015 | 159 | 0.450 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2015 | 143 | 0.450 |
Why?
|
| Education, Medical, Continuing | 1 | 2014 | 105 | 0.450 |
Why?
|
| Bronchial Spasm | 1 | 2013 | 15 | 0.440 |
Why?
|
| Heroin | 1 | 2013 | 11 | 0.430 |
Why?
|
| Narcotics | 1 | 2013 | 70 | 0.410 |
Why?
|
| Stroke | 3 | 2018 | 986 | 0.410 |
Why?
|
| Attitude of Health Personnel | 1 | 2017 | 645 | 0.400 |
Why?
|
| Myocardial Infarction | 1 | 2014 | 374 | 0.380 |
Why?
|
| Triage | 2 | 2021 | 111 | 0.360 |
Why?
|
| Clinical Competence | 1 | 2014 | 784 | 0.320 |
Why?
|
| Chicago | 3 | 2021 | 1427 | 0.270 |
Why?
|
| Urban Health Services | 2 | 2017 | 45 | 0.260 |
Why?
|
| United States | 5 | 2023 | 6989 | 0.260 |
Why?
|
| Rh-Hr Blood-Group System | 1 | 2024 | 14 | 0.240 |
Why?
|
| Humans | 20 | 2024 | 89357 | 0.230 |
Why?
|
| Air Ambulances | 1 | 2024 | 27 | 0.230 |
Why?
|
| Community Health Services | 1 | 2023 | 82 | 0.200 |
Why?
|
| ST Elevation Myocardial Infarction | 1 | 2021 | 12 | 0.200 |
Why?
|
| Workflow | 1 | 2022 | 80 | 0.190 |
Why?
|
| Patient Identification Systems | 1 | 2021 | 7 | 0.190 |
Why?
|
| Hypoglycemia | 1 | 2022 | 107 | 0.190 |
Why?
|
| Adult | 9 | 2024 | 26607 | 0.180 |
Why?
|
| Aged | 7 | 2023 | 19165 | 0.180 |
Why?
|
| Midazolam | 1 | 2020 | 48 | 0.180 |
Why?
|
| Pilot Projects | 1 | 2023 | 871 | 0.180 |
Why?
|
| Exercise | 1 | 2023 | 323 | 0.170 |
Why?
|
| Middle Aged | 8 | 2023 | 25974 | 0.170 |
Why?
|
| Medicare | 1 | 2023 | 425 | 0.170 |
Why?
|
| Health Education | 2 | 2021 | 105 | 0.160 |
Why?
|
| Hypnotics and Sedatives | 1 | 2020 | 131 | 0.160 |
Why?
|
| Physicians | 2 | 2017 | 690 | 0.150 |
Why?
|
| Hospitals | 1 | 2021 | 299 | 0.150 |
Why?
|
| Emergency Medical Service Communication Systems | 1 | 2017 | 6 | 0.150 |
Why?
|
| Arterial Occlusive Diseases | 1 | 2018 | 110 | 0.140 |
Why?
|
| Pandemics | 1 | 2023 | 773 | 0.140 |
Why?
|
| Focus Groups | 1 | 2017 | 172 | 0.140 |
Why?
|
| Mental Disorders | 1 | 2020 | 414 | 0.130 |
Why?
|
| Infant | 1 | 2023 | 3160 | 0.130 |
Why?
|
| Child, Preschool | 1 | 2023 | 3731 | 0.130 |
Why?
|
| Administration, Inhalation | 2 | 2013 | 190 | 0.130 |
Why?
|
| Health Knowledge, Attitudes, Practice | 2 | 2021 | 533 | 0.120 |
Why?
|
| Young Adult | 3 | 2023 | 6312 | 0.120 |
Why?
|
| Models, Educational | 1 | 2014 | 49 | 0.120 |
Why?
|
| Health Services Research | 1 | 2014 | 137 | 0.110 |
Why?
|
| Communication | 1 | 2017 | 460 | 0.110 |
Why?
|
| Quality Assurance, Health Care | 1 | 2015 | 225 | 0.110 |
Why?
|
| Brain Ischemia | 1 | 2018 | 400 | 0.110 |
Why?
|
| Ischemia | 1 | 2015 | 251 | 0.110 |
Why?
|
| Adolescent | 2 | 2023 | 9263 | 0.100 |
Why?
|
| Child | 1 | 2023 | 7174 | 0.100 |
Why?
|
| Female | 8 | 2024 | 46202 | 0.100 |
Why?
|
| Administration, Intranasal | 2 | 2022 | 137 | 0.090 |
Why?
|
| Retrospective Studies | 6 | 2022 | 9057 | 0.090 |
Why?
|
| Prevalence | 1 | 2014 | 1243 | 0.090 |
Why?
|
| Male | 7 | 2021 | 42411 | 0.090 |
Why?
|
| Incidence | 1 | 2014 | 1595 | 0.090 |
Why?
|
| Curriculum | 1 | 2014 | 568 | 0.090 |
Why?
|
| Machine Learning | 2 | 2022 | 258 | 0.080 |
Why?
|
| Cross-Sectional Studies | 1 | 2015 | 1714 | 0.080 |
Why?
|
| Surveys and Questionnaires | 1 | 2017 | 2624 | 0.080 |
Why?
|
| Aged, 80 and over | 2 | 2018 | 6811 | 0.070 |
Why?
|
| Treatment Outcome | 3 | 2020 | 8241 | 0.070 |
Why?
|
| Analgesics, Opioid | 1 | 2011 | 444 | 0.070 |
Why?
|
| Registries | 2 | 2022 | 784 | 0.060 |
Why?
|
| Time Factors | 1 | 2014 | 5338 | 0.060 |
Why?
|
| Erythroblastosis, Fetal | 1 | 2024 | 11 | 0.060 |
Why?
|
| Erythrocyte Transfusion | 1 | 2024 | 72 | 0.060 |
Why?
|
| Secondary Care Centers | 1 | 2021 | 2 | 0.050 |
Why?
|
| Glucagon | 1 | 2022 | 111 | 0.050 |
Why?
|
| Comprehensive Health Care | 1 | 2021 | 13 | 0.050 |
Why?
|
| Area Under Curve | 1 | 2022 | 337 | 0.050 |
Why?
|
| Transportation of Patients | 1 | 2021 | 32 | 0.050 |
Why?
|
| American Heart Association | 1 | 2021 | 95 | 0.050 |
Why?
|
| Patient Transfer | 1 | 2021 | 94 | 0.050 |
Why?
|
| Injections, Intramuscular | 1 | 2020 | 64 | 0.040 |
Why?
|
| Administration, Intravenous | 1 | 2020 | 57 | 0.040 |
Why?
|
| Allied Health Personnel | 1 | 2020 | 20 | 0.040 |
Why?
|
| ROC Curve | 1 | 2022 | 781 | 0.040 |
Why?
|
| Health Policy | 1 | 2021 | 185 | 0.040 |
Why?
|
| Clinical Protocols | 1 | 2020 | 157 | 0.040 |
Why?
|
| Emergencies | 1 | 2020 | 121 | 0.040 |
Why?
|
| Disease Management | 1 | 2021 | 329 | 0.040 |
Why?
|
| Clinical Decision-Making | 1 | 2021 | 281 | 0.040 |
Why?
|
| Models, Theoretical | 1 | 2022 | 491 | 0.040 |
Why?
|
| Drug Administration Schedule | 1 | 2020 | 895 | 0.040 |
Why?
|
| Blood Glucose | 1 | 2022 | 836 | 0.040 |
Why?
|
| Primary Health Care | 1 | 2021 | 351 | 0.040 |
Why?
|
| Endovascular Procedures | 1 | 2021 | 276 | 0.040 |
Why?
|
| Ambulances | 1 | 2017 | 15 | 0.040 |
Why?
|
| Pregnancy | 1 | 2024 | 3018 | 0.030 |
Why?
|
| Decision Making | 1 | 2022 | 667 | 0.030 |
Why?
|
| Tissue Plasminogen Activator | 1 | 2018 | 171 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2020 | 1942 | 0.030 |
Why?
|
| Practice Guidelines as Topic | 1 | 2021 | 1047 | 0.030 |
Why?
|
| Logistic Models | 1 | 2018 | 1213 | 0.030 |
Why?
|
| Predictive Value of Tests | 1 | 2018 | 1723 | 0.030 |
Why?
|
| Safety Management | 1 | 2011 | 56 | 0.020 |
Why?
|
| Nebulizers and Vaporizers | 1 | 2011 | 56 | 0.020 |
Why?
|
| Drug Overdose | 1 | 2011 | 74 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2018 | 4289 | 0.020 |
Why?
|
| Opioid-Related Disorders | 1 | 2011 | 189 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2011 | 2872 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2011 | 3666 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2011 | 2303 | 0.010 |
Why?
|